CN Stock MarketDetailed Quotes

688373 Shanghai Micurx Pharmaceutical

Watchlist
  • 4.67
  • -0.04-0.85%
Market Closed May 15 15:00 CST
3.06BMarket Cap-6549P/E (TTM)

Shanghai Micurx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
91.10%33.02M
88.31%90.78M
95.87%68.27M
106.60%42.11M
61.66%17.28M
529.33%48.21M
534.91%34.86M
20.38M
10.69M
7.66M
Operating revenue
91.10%33.02M
88.31%90.78M
95.87%68.27M
106.60%42.11M
61.66%17.28M
529.33%48.21M
534.91%34.86M
--20.38M
--10.69M
--7.66M
Total operating cost
68.53%140.53M
70.60%538.48M
49.64%335.65M
38.65%184.85M
26.40%83.38M
12.75%315.65M
33.20%224.31M
23.57%133.32M
44.88%65.97M
188.84%279.96M
Operating cost
72.03%5.81M
89.25%16.7M
99.08%12.5M
120.36%7.87M
112.70%3.38M
1,425.32%8.82M
2,348.19%6.28M
--3.57M
--1.59M
--578.38K
Operating tax surcharges
16.13%68.5K
117.40%296.27K
25.90%162.45K
24.97%119.44K
1,081.56%58.98K
306.73%136.28K
2,419.78%129.03K
161,533.13%95.57K
344,155.17%4.99K
-90.57%33.51K
Operating expense
96.83%30.29M
30.16%107.41M
31.88%69.16M
42.98%44.73M
1.14%15.39M
24.62%82.52M
38.48%52.44M
37.25%31.28M
56.83%15.21M
1,413.89%66.22M
Administration expense
-0.95%16.84M
-3.91%61.17M
-8.68%43.34M
5.65%30.09M
16.89%17M
9.45%63.66M
13.19%47.46M
4.70%28.48M
34.27%14.54M
59.54%58.16M
Financial expense
-29.68%2.88M
-20.41%8.06M
146.54%7.54M
36.80%5.95M
140.16%4.09M
214.81%10.12M
78.54%3.06M
497.25%4.35M
674.85%1.7M
120.22%3.22M
-Interest expense (Financial expense)
2.86%1.23M
14.97%10.14M
16.84%7.39M
20.97%5.33M
-46.59%1.19M
68.50%8.82M
99.53%6.32M
--4.41M
2,331.71%2.23M
114.77%5.23M
-Interest Income (Financial expense)
-172.44%-1.22M
50.33%-2.19M
60.43%-1.49M
26.47%-894.82K
29.45%-449.07K
-83.74%-4.4M
-131.17%-3.76M
---1.22M
-73.59%-636.54K
-139.54%-2.39M
Research and development
94.73%84.65M
129.31%344.86M
76.57%202.95M
46.61%96.1M
32.06%43.47M
-0.90%150.39M
32.69%114.94M
14.64%65.55M
30.11%32.92M
179.57%151.76M
Credit Impairment Loss
-1,108.28%-98.62K
-233.10%-328.02K
-161.14%-174.79K
172.39%114.06K
108.12%9.78K
172.49%246.45K
92.84%285.88K
-2,350.41%-157.56K
-185.03%-120.48K
-3,019.28%-339.99K
Asset Impairment Loss
----
----
----
----
----
----
----
----
----
---181.19K
Other net revenue
Fair value change income
-45.62%5.29M
80.32%33.34M
140.40%27.13M
618.25%21.49M
362.67%9.73M
75.61%18.49M
36.50%11.29M
-45.89%2.99M
-35.14%2.1M
7,593.35%10.53M
Asset deal income
----
-99.72%1.46K
-99.72%1.46K
-99.72%1.46K
----
--513.69K
--520.24K
--520.24K
--520.24K
----
Other revenue
-6.90%184.78K
-85.01%3.78M
56.74%198.46K
83.29%198.46K
404.49%198.46K
310.85%25.25M
-96.93%126.62K
-12.71%108.28K
40.89%39.34K
2,340.03%6.15M
Operating profit
-81.85%-102.13M
-84.31%-410.9M
-35.54%-240.22M
-10.47%-120.94M
-6.49%-56.16M
12.97%-222.94M
-17.73%-177.23M
-6.88%-109.48M
-25.21%-52.74M
-164.54%-256.15M
Add:Non operating Income
----
----
----
----
----
-87.62%3.71M
-86.10%3.49M
-88.81%1.75M
-74.50%1.71M
184.66%29.94M
Less:Non operating expense
--5.8K
300.18%4.25M
18,645.14%4.23M
31,950.11%4.18M
----
4,816.01%1.06M
1,240.82%22.57K
674.63%13.04K
674.63%13.04K
117.64%21.6K
Total profit
-81.86%-102.14M
-88.45%-415.15M
-40.68%-244.45M
-16.13%-125.12M
-10.04%-56.16M
2.62%-220.29M
-38.50%-173.77M
-24.13%-107.74M
-44.16%-51.04M
-162.08%-226.23M
Less:Income tax cost
----
110,872.86%5.97M
6.18%5.61K
6.87%5.54K
----
-86.15%5.38K
-86.42%5.29K
1.07%5.19K
----
604.19%38.86K
Net profit
FPtoL-102.14M
FPtoL-421.12M
FPtoL-244.46M
FPtoL-125.12M
FPtoL-56.16M
FPtoL-220.3M
FPtoL-173.77M
FPtoL-107.75M
FPtoL-51.04M
FPtoL-226.27M
Net profit from continuing operation
-81.86%-102.14M
-91.16%-421.12M
-40.68%-244.46M
-16.13%-125.12M
-10.04%-56.16M
2.64%-220.3M
-38.47%-173.77M
---107.75M
-44.14%-51.04M
-162.11%-226.27M
Net profit of parent company owners
-81.86%-102.14M
-91.16%-421.12M
-40.68%-244.46M
-16.13%-125.12M
-10.04%-56.16M
2.64%-220.3M
-38.47%-173.77M
-24.13%-107.75M
-44.14%-51.04M
-162.11%-226.27M
Earning per share
Basic earning per share
-77.78%-0.16
-68.42%-0.64
-19.35%-0.37
9.52%-0.19
10.00%-0.09
11.63%-0.38
-29.17%-0.31
---0.21
-42.86%-0.1
-26.47%-0.43
Diluted earning per share
-77.78%-0.16
-68.42%-0.64
-19.35%-0.37
9.52%-0.19
10.00%-0.09
11.63%-0.38
-29.17%-0.31
---0.21
-42.86%-0.1
-26.47%-0.43
Other composite income
115.40%673.64K
-55.01%3.71M
84.20%10.84M
403.06%12.15M
-4,068.42%-4.37M
948.19%8.26M
4,782.27%5.89M
1,680.78%2.42M
-145.19%-104.95K
-154.29%-973.27K
Other composite income of parent company owners
115.40%673.64K
-55.01%3.71M
84.20%10.84M
403.06%12.15M
-4,068.42%-4.37M
948.19%8.26M
4,782.27%5.89M
--2.42M
---104.95K
---973.27K
Add:Adjusted items effecting composite income
----
----
----
----
----
----
----
--0.01
----
----
Total composite income
-67.61%-101.46M
-96.85%-417.41M
-39.15%-233.62M
-7.25%-112.97M
-18.37%-60.54M
6.69%-212.04M
-33.64%-167.89M
-21.53%-105.33M
-44.26%-51.14M
-168.82%-227.24M
Total composite income of parent company owners
-67.61%-101.46M
-96.85%-417.41M
-39.15%-233.62M
-7.25%-112.97M
-18.37%-60.54M
6.69%-212.04M
-33.64%-167.89M
-21.53%-105.33M
-44.26%-51.14M
-168.82%-227.24M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 91.10%33.02M88.31%90.78M95.87%68.27M106.60%42.11M61.66%17.28M529.33%48.21M534.91%34.86M20.38M10.69M7.66M
Operating revenue 91.10%33.02M88.31%90.78M95.87%68.27M106.60%42.11M61.66%17.28M529.33%48.21M534.91%34.86M--20.38M--10.69M--7.66M
Total operating cost 68.53%140.53M70.60%538.48M49.64%335.65M38.65%184.85M26.40%83.38M12.75%315.65M33.20%224.31M23.57%133.32M44.88%65.97M188.84%279.96M
Operating cost 72.03%5.81M89.25%16.7M99.08%12.5M120.36%7.87M112.70%3.38M1,425.32%8.82M2,348.19%6.28M--3.57M--1.59M--578.38K
Operating tax surcharges 16.13%68.5K117.40%296.27K25.90%162.45K24.97%119.44K1,081.56%58.98K306.73%136.28K2,419.78%129.03K161,533.13%95.57K344,155.17%4.99K-90.57%33.51K
Operating expense 96.83%30.29M30.16%107.41M31.88%69.16M42.98%44.73M1.14%15.39M24.62%82.52M38.48%52.44M37.25%31.28M56.83%15.21M1,413.89%66.22M
Administration expense -0.95%16.84M-3.91%61.17M-8.68%43.34M5.65%30.09M16.89%17M9.45%63.66M13.19%47.46M4.70%28.48M34.27%14.54M59.54%58.16M
Financial expense -29.68%2.88M-20.41%8.06M146.54%7.54M36.80%5.95M140.16%4.09M214.81%10.12M78.54%3.06M497.25%4.35M674.85%1.7M120.22%3.22M
-Interest expense (Financial expense) 2.86%1.23M14.97%10.14M16.84%7.39M20.97%5.33M-46.59%1.19M68.50%8.82M99.53%6.32M--4.41M2,331.71%2.23M114.77%5.23M
-Interest Income (Financial expense) -172.44%-1.22M50.33%-2.19M60.43%-1.49M26.47%-894.82K29.45%-449.07K-83.74%-4.4M-131.17%-3.76M---1.22M-73.59%-636.54K-139.54%-2.39M
Research and development 94.73%84.65M129.31%344.86M76.57%202.95M46.61%96.1M32.06%43.47M-0.90%150.39M32.69%114.94M14.64%65.55M30.11%32.92M179.57%151.76M
Credit Impairment Loss -1,108.28%-98.62K-233.10%-328.02K-161.14%-174.79K172.39%114.06K108.12%9.78K172.49%246.45K92.84%285.88K-2,350.41%-157.56K-185.03%-120.48K-3,019.28%-339.99K
Asset Impairment Loss ---------------------------------------181.19K
Other net revenue
Fair value change income -45.62%5.29M80.32%33.34M140.40%27.13M618.25%21.49M362.67%9.73M75.61%18.49M36.50%11.29M-45.89%2.99M-35.14%2.1M7,593.35%10.53M
Asset deal income -----99.72%1.46K-99.72%1.46K-99.72%1.46K------513.69K--520.24K--520.24K--520.24K----
Other revenue -6.90%184.78K-85.01%3.78M56.74%198.46K83.29%198.46K404.49%198.46K310.85%25.25M-96.93%126.62K-12.71%108.28K40.89%39.34K2,340.03%6.15M
Operating profit -81.85%-102.13M-84.31%-410.9M-35.54%-240.22M-10.47%-120.94M-6.49%-56.16M12.97%-222.94M-17.73%-177.23M-6.88%-109.48M-25.21%-52.74M-164.54%-256.15M
Add:Non operating Income ---------------------87.62%3.71M-86.10%3.49M-88.81%1.75M-74.50%1.71M184.66%29.94M
Less:Non operating expense --5.8K300.18%4.25M18,645.14%4.23M31,950.11%4.18M----4,816.01%1.06M1,240.82%22.57K674.63%13.04K674.63%13.04K117.64%21.6K
Total profit -81.86%-102.14M-88.45%-415.15M-40.68%-244.45M-16.13%-125.12M-10.04%-56.16M2.62%-220.29M-38.50%-173.77M-24.13%-107.74M-44.16%-51.04M-162.08%-226.23M
Less:Income tax cost ----110,872.86%5.97M6.18%5.61K6.87%5.54K-----86.15%5.38K-86.42%5.29K1.07%5.19K----604.19%38.86K
Net profit FPtoL-102.14MFPtoL-421.12MFPtoL-244.46MFPtoL-125.12MFPtoL-56.16MFPtoL-220.3MFPtoL-173.77MFPtoL-107.75MFPtoL-51.04MFPtoL-226.27M
Net profit from continuing operation -81.86%-102.14M-91.16%-421.12M-40.68%-244.46M-16.13%-125.12M-10.04%-56.16M2.64%-220.3M-38.47%-173.77M---107.75M-44.14%-51.04M-162.11%-226.27M
Net profit of parent company owners -81.86%-102.14M-91.16%-421.12M-40.68%-244.46M-16.13%-125.12M-10.04%-56.16M2.64%-220.3M-38.47%-173.77M-24.13%-107.75M-44.14%-51.04M-162.11%-226.27M
Earning per share
Basic earning per share -77.78%-0.16-68.42%-0.64-19.35%-0.379.52%-0.1910.00%-0.0911.63%-0.38-29.17%-0.31---0.21-42.86%-0.1-26.47%-0.43
Diluted earning per share -77.78%-0.16-68.42%-0.64-19.35%-0.379.52%-0.1910.00%-0.0911.63%-0.38-29.17%-0.31---0.21-42.86%-0.1-26.47%-0.43
Other composite income 115.40%673.64K-55.01%3.71M84.20%10.84M403.06%12.15M-4,068.42%-4.37M948.19%8.26M4,782.27%5.89M1,680.78%2.42M-145.19%-104.95K-154.29%-973.27K
Other composite income of parent company owners 115.40%673.64K-55.01%3.71M84.20%10.84M403.06%12.15M-4,068.42%-4.37M948.19%8.26M4,782.27%5.89M--2.42M---104.95K---973.27K
Add:Adjusted items effecting composite income ------------------------------0.01--------
Total composite income -67.61%-101.46M-96.85%-417.41M-39.15%-233.62M-7.25%-112.97M-18.37%-60.54M6.69%-212.04M-33.64%-167.89M-21.53%-105.33M-44.26%-51.14M-168.82%-227.24M
Total composite income of parent company owners -67.61%-101.46M-96.85%-417.41M-39.15%-233.62M-7.25%-112.97M-18.37%-60.54M6.69%-212.04M-33.64%-167.89M-21.53%-105.33M-44.26%-51.14M-168.82%-227.24M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg